PD3D®models as jacks-of-all-trades for cancer research and therapy response prediction

L Wedeken, S Forbrig, K Herrera-Glomm, J Loskutov… - Cancer Research, 2024 - AACR
Physiologically relevant in vitro tumor models are crucial in any research setting from
preclinical drug development to functional precision oncology. Patient-derived 3D cell …

PD3D®models: New age in cancer research and clinical diagnostics

A Pflaume, S Exner, K Herrera-Glomm, J Loskutov… - Cancer Research, 2022 - AACR
Patient-derived 3D cell culture models (PD3D®) developed as a powerful tool for disease
modelling, biomarker and drug discovery. Currently, they are gaining increasing significance …

An innovative PDX and patient-derived 3D platform for improved translatability of new medical entities

S Kamali, S Cairo, FJ Chou, T Light, M Gilardi… - Cancer Research, 2024 - AACR
The preclinical platform landscape in oncology has radically changed in the last 15 years,
mainly due to an increased ability to generate patient-derived models. Multiple 3D tumor cell …

Mix and match-A comprehensive pipeline for matched patient-derived PDX and PD3D® modelsfor cancer research and preclinical drug development

J Loskutov, E Oswald, L Wedeken, CJ Reinhard… - Cancer Research, 2024 - AACR
Relevant in vivo and in vitro cancer models have been invaluable for our current
understanding of cancer biology, as well as for therapy development. Using appropriate …

Establishment of PD3D models of sarcomas: A promising preclinical tool for improvement of sarcoma treatment.

M Regenbrecht, R Sauer, M Niethard… - 2022 - ascopubs.org
e23538 Background: Compared to the progress in understanding and treating carcinomas
in the past decade, the options and related clinical benefit in terms of response rates and …

A patient-centric repository of PDX models for translational oncology research

TO Khor, I Ben Zvi, A Katz, D Vasquez-Dunddel… - Cancer research, 2015 - AACR
Patient-derived xenograft (PDX) models maintain the complex intra-tumoral biology and
heterogeneity of an intact malignancy, as well as the interplay with stromal components and …

Enhancing Precision Oncology: Preclinical Assessment of Individual Drug Treatment Susceptibility Using Patient-Derived 3D Microtumor and Immune Cell Co-cultures

N Anderle - 2024 - tobias-lib.ub.uni-tuebingen.de
Despite 50 years of dedicated efforts in the" War on Cancer", the results achieved in treating
cancer have been regrettably unsatisfactory. Particularly challenging are tumors …

Drug screening in 3D in vitro tumor models: overcoming current pitfalls of efficacy read‐outs

VE Santo, SP Rebelo, MF Estrada… - Biotechnology …, 2017 - Wiley Online Library
There is cumulating evidence that in vitro 3D tumor models with increased physiological
relevance can improve the predictive value of pre‐clinical research and ultimately contribute …

[HTML][HTML] harnessing the power of patient derived models of cancer

SR Pine, HE Sabaawy - Frontiers in Oncology, 2018 - frontiersin.org
We are honored to introduce a collection of five original research articles, protocols, reviews,
and perspectives on the research topic “Harnessing the Power of Patient Derived Models of …

Characterization of 3D models of human breast, prostate and colorectal cancer

K Hudson, N Cross, N Jordan-Mahy, R Leyland - Cancer Research, 2021 - AACR
Tumorigenic expression of programmed death-ligand 1 (PD-L1) and its receptor PD-1 is
found in many cancers, though the intrinsic roles of these proteins and how immunotherapy …